| Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity PA Gurbel, KP Bliden, BL Hiatt, CM O’Connor Circulation 107 (23), 2908-2913, 2003 | 2239 | 2003 |
| Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ... The American journal of cardiology 92 (2), 152-160, 2003 | 2222 | 2003 |
| Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the … PA Gurbel, KP Bliden, K Butler, US Tantry, T Gesheff, C Wei, R Teng, ... Circulation 120 (25), 2577-2585, 2009 | 2043* | 2009 |
| Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy AR Shuldiner, JR O’Connell, KP Bliden, A Gandhi, K Ryan, ... Jama 302 (8), 849-857, 2009 | 1807 | 2009 |
| Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis JL Mega, T Simon, JP Collet, JL Anderson, EM Antman, K Bliden, ... Jama 304 (16), 1821-1830, 2010 | 1440 | 2010 |
| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1372 | 2010 |
| Prasugrel versus clopidogrel for acute coronary syndromes without revascularization MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ... New England journal of medicine 367 (14), 1297-1309, 2012 | 1105 | 2012 |
| Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study GW Stone, B Witzenbichler, G Weisz, MJ Rinaldi, FJ Neumann, ... The Lancet 382 (9892), 614-623, 2013 | 992 | 2013 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 983 | 2018 |
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 950 | 2013 |
| Ticagrelor with or without aspirin in high-risk patients after PCI R Mehran, U Baber, SK Sharma, DJ Cohen, DJ Angiolillo, C Briguori, ... New England Journal of Medicine 381 (21), 2032-2042, 2019 | 916 | 2019 |
| Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study PA Gurbel, KP Bliden, K Guyer, PW Cho, KA Zaman, RP Kreutz, AK Bassi, ... Journal of the American College of Cardiology 46 (10), 1820-1826, 2005 | 867 | 2005 |
| Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance WC Lau, PA Gurbel, PB Watkins, CJ Neer, AS Hopp, DGM Carville, ... Circulation 109 (2), 166-171, 2004 | 792 | 2004 |
| Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study PA Gurbel, KP Bliden, W Samara, JA Yoho, K Hayes, MZ Fissha, ... Journal of the American College of Cardiology 46 (10), 1827-1832, 2005 | 757 | 2005 |
| Ischemia and no obstructive coronary artery disease (INOCA) developing evidence-based therapies and research agenda for the next decade CN Bairey Merz, CJ Pepine, MN Walsh, JL Fleg, PG Camici, WM Chilian, ... Circulation 135 (11), 1075-1092, 2017 | 711 | 2017 |
| Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study PA Gurbel, KP Bliden, K Butler, MJ Antonino, C Wei, R Teng, ... Circulation 121 (10), 1188-1199, 2010 | 691 | 2010 |
| Platelet function monitoring in patients with coronary artery disease PA Gurbel, RC Becker, KG Mann, SR Steinhubl, AD Michelson Journal of the American College of Cardiology 50 (19), 1822-1834, 2007 | 638 | 2007 |
| Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary … RF Storey, S Husted, RA Harrington, S Heptinstall, RG Wilcox, G Peters, ... Journal of the American College of Cardiology 50 (19), 1852-1856, 2007 | 622 | 2007 |
| Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis EP Navarese, M Kołodziejczak, V Schulze, PA Gurbel, U Tantry, Y Lin, ... Annals of internal medicine 163 (1), 40-51, 2015 | 562 | 2015 |
| Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet … KP Bliden, J DiChiara, US Tantry, AK Bassi, SK Chaganti, PA Gurbel Journal of the American College of Cardiology 49 (6), 657-666, 2007 | 555 | 2007 |
